ArticleInternational journal of pharmaceutics: X2025
Self-assembling rose-derived nanovesicles: A multifunctional tool for tissue regeneration.
Article in International journal of pharmaceutics: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of biocompatible nanotherapeutics for skin regeneration remains a major goal in regenerative medicine. Here, we report the isolation and characterization of rose petal-derived extracellular vesicle-like nanovesicles (RPDNVs) obtained by differential ultracentrifugation and size exclusion chromatography. Comprehensive physicochemical analyses confirmed their vesicular morphology, nanoscale size distribution, and antioxidant-enriched molecular cargo, including lipids, phenols, and proteins. RPDNVs demonstrated mechanical stability compatible with tissue interfacing. Functionally, they enhanced fibroblast migration and modulated extracellular matrix gene expression without inducing fibrotic responses. Their biocompatibility was confirmed by in vitro and in vivo studies on human volunteers, thus supporting their translational relevance. Notably, RPDNVs retained structural and functional stability following freeze-drying in the absence of cryoprotectants, enabling long-term storage. These results establish RPDNVs as a promising class of plant-derived nanocarriers for therapeutic skin repair.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.